title: May depressed and anxious patients with carcinoid syndrome benefit from treatment with selective serotonin reuptake inhibitors (SSRIs)?: findings from a case report.
authors.affiliation: a Department of Psychiatry , Ghent University Hospital , Ghent , Belgium.
authors.forename: Anne
authors.initials: A
authors.lastname: Nobels
authors.affiliation: b Department of Oncology , Ghent University Hospital , Ghent , Belgium.
authors.forename: Karen
authors.initials: K
authors.lastname: Geboes
authors.affiliation: a Department of Psychiatry , Ghent University Hospital , Ghent , Belgium.
authors.forename: Gilbert M D
authors.initials: GM
authors.lastname: Lemmens
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use; D001007:Anxiety / Q000188:drug therapy*; D002275:Carcinoid Heart Disease / Q000139:chemically induced; D002276:Carcinoid Tumor / Q000188:drug therapy* / Q000473:pathology / Q000523:psychology; D015283:Citalopram / Q000008:administration & dosage / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008875:Middle Aged; D015282:Octreotide / Q000009:adverse effects / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
chemical_list: D018687:Antidepressive Agents, Second-Generation; D018931:Antineoplastic Agents, Hormonal; D015283:Citalopram; D015282:Octreotide; D017367:Selective Serotonin Reuptake Inhibitors